Related Experiment Video
Updated: Jul 4, 2025
09:44
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
10.1K
COMPARATIVE ANALYSIS OF THE EFFECTS OF SOME HEPATOPROTECTORS IN EXPERIMENTALLY INDUCED MAFLD IN ADULT WISTAR RATS
D Kachanov1, M Artsygov1, M Omarov1
11NWSMU named after I.I. Mechnikov, Saint-Petersburg, Russia.
Georgian Medical News
|February 7, 2024
Summary
Metabolic associated fatty liver disease (MAFLD) is a growing pandemic. This study compared the effectiveness of various hepatoprotectors in treating MAFLD in rats, offering insights into potential therapeutic strategies.
Area of Science:
- Hepatology
- Pharmacology
- Animal Models
Background:
- Metabolic associated fatty liver disease (MAFLD) is a prevalent chronic condition marked by liver fat accumulation and metabolic dysfunction.
- MAFLD is escalating to pandemic levels globally.
- Pharmacotherapy, including hepatoprotectors, is a key component in managing MAFLD alongside lifestyle interventions.
Purpose of the Study:
- To conduct a comparative analysis of the efficacy of selected hepatoprotective agents.
- To evaluate the therapeutic potential of these agents in an experimental MAFLD model.
Main Methods:
- Induction of MAFLD in adult Wistar rats.
- Administration of various hepatoprotectors.
- Comparative assessment of treatment efficacy.
Main Results:
- The study identified significant differences in the efficacy of the tested hepatoprotectors.
- Specific agents demonstrated notable protective effects against experimentally induced MAFLD.
- Detailed results on biochemical and histological parameters were analyzed.
Conclusions:
- Certain hepatoprotectors show promise for MAFLD treatment.
- This research provides a basis for further investigation into optimal pharmacotherapy for MAFLD.
- Findings contribute to understanding MAFLD management strategies in preclinical models.
